Pages that link to "Q38062048"
Jump to navigation
Jump to search
The following pages link to CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils (Q38062048):
Displaying 15 items.
- Lipid mediators and allergic diseases (Q27023936) (← links)
- Pathogenic CD4 T cells in patients with asthma (Q30252507) (← links)
- 15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction (Q33631228) (← links)
- Novel investigational therapies for atopic dermatitis (Q38247119) (← links)
- Immunopathology of chronic rhinosinusitis. (Q38403174) (← links)
- Investigational prostaglandin D2 receptor antagonists for airway inflammation (Q38812321) (← links)
- Depletion of major pathogenic cells in asthma by targeting CRTh2. (Q40517997) (← links)
- Pathological and therapeutic roles of innate lymphoid cells in diverse diseases (Q47897160) (← links)
- Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma (Q50636722) (← links)
- Pathogenesis of Recalcitrant Chronic Rhinosinusitis: The Emerging Role of Innate Immune Cells. (Q55242373) (← links)
- The prostaglandin D receptor 2 pathway in asthma: a key player in airway inflammation (Q58795817) (← links)
- Revisiting Therapies for Atopic Dermatitis that Failed Clinical Trials (Q90331868) (← links)
- Targeting cell signaling in allergic asthma (Q90862887) (← links)
- Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria (Q92414706) (← links)
- Stability of peripheral blood immune markers in patients with asthma (Q92550282) (← links)